No cardiac sequelae after COVID-19: results of the one year
follow-up with echocardiography and biomarkers

a 2022

No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ et al.

Základní údaje

Originální název

No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

Autoři

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ; Jana HOŘÍNKOVÁ; Radka ŠTĚPÁNOVÁ a Petr KALA

Vydání

ESC Congress 2022 - Barcelona, Spain 26-29 August 2022, 2022

Další údaje

Jazyk

angličtina

Typ výsledku

Konferenční abstrakt

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/22:00127763

Organizační jednotka

Lékařská fakulta

DOI

https://doi.org/10.1093/eurheartj/ehac544.1540

Klíčová slova česky

COVID-19; SARS-CoV-2; clinical evaluation; cardiac biomarkers; cardiac sequelae

Klíčová slova anglicky

COVID-19; SARS-CoV-2; clinical evaluation; cardiac biomarkers; cardiac sequelae

Štítky

Excelence Science, FN Brno, MU, RIV, rivok, článek v časopise

Příznaky

Mezinárodní význam

Změněno: 5. 4. 2023 13:39, Mgr. Tereza Miškechová

Anotace

V originále

Abstract Objective To evaluate the need for cardiac monitoring of unselected patients recovered from COVID-19 and to estimate the risk of heart failure development after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods During March 2020 and January 2021, 106 patients recovered from SARS-CoV-2 (alfa and beta variants) were enrolled in the prospective observational cohort study, CoSuBr (Covid Survivals in Brno). The diagnosis was established by reverse transcription polymerase chain reaction on swab test of the upper respiratory tract. Demographic parameters, patient history, clinical evaluation, cardiac biomarkers, ECG and echocardiography were recorded within three visits (V1 at least six weeks after infection, V2 three months later and V3 one year after V1).

Návaznosti

LX22NPO5107, projekt VaV

Název: Národní ústav pro neurologický výzkum

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Národní ústav pro neurologický výzkum, 5.1 EXCELES

90128, velká výzkumná infrastruktura

Název: CZECRIN III

Přiložené soubory

No_cardiac_sequelae_after_COVID-19_results_of_the_one_year_follow-up_with_echocardiography_and.pdf Verze souboru

Citovat

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ; Jana HOŘÍNKOVÁ; Radka ŠTĚPÁNOVÁ a Petr KALA. No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers. In ESC Congress 2022 - Barcelona, Spain 26-29 August 2022. 2022. Dostupné z: https://doi.org/10.1093/eurheartj/ehac544.1540.

@proceedings{2244047,
   author = {Radvan, Martin and Kameník, Martin and Koc, Lumír and Matejová, Gabriela and Bartečková, Eliška and Hořínková, Jana and Štěpánová, Radka and Kala, Petr},
   booktitle = {ESC Congress 2022 - Barcelona, Spain 26-29 August 2022},
   doi = {https://doi.org/10.1093/eurheartj/ehac544.1540},
   keywords = {COVID-19; SARS-CoV-2; clinical evaluation; cardiac biomarkers; cardiac sequelae},
   language = {eng},
   title = {No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers},
   url = {https://academic.oup.com/eurheartj/article/43/Supplement_2/ehac544.1540/6745361},
   year = {2022}
}

TY  - CONF
ID  - 2244047
AU  - Radvan, Martin - Kameník, Martin - Koc, Lumír - Matejová, Gabriela - Bartečková, Eliška - Hořínková, Jana - Štěpánová, Radka - Kala, Petr
PY  - 2022
TI  - No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
KW  - COVID-19
KW  - SARS-CoV-2
KW  - clinical evaluation
KW  - cardiac biomarkers
KW  - cardiac sequelae
UR  - https://academic.oup.com/eurheartj/article/43/Supplement_2/ehac544.1540/6745361
N2  - Abstract Objective To evaluate the need for cardiac monitoring of unselected patients recovered from COVID-19 and to estimate the risk of heart failure development after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods During March 2020 and January 2021, 106 patients recovered from SARS-CoV-2 (alfa and beta variants) were enrolled in the prospective observational cohort study, CoSuBr (Covid Survivals in Brno). The diagnosis was established by reverse transcription polymerase chain reaction on swab test of the upper respiratory tract. Demographic parameters, patient history, clinical evaluation, cardiac biomarkers, ECG and echocardiography were recorded within three visits (V1 at least six weeks after infection, V2 three months later and V3 one year after V1).
ER  -

RADVAN, Martin; Martin KAMENÍK; Lumír KOC; Gabriela MATEJOVÁ; Eliška BARTEČKOVÁ; Jana HOŘÍNKOVÁ; Radka ŠTĚPÁNOVÁ a Petr KALA. No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers. In \textit{ESC Congress 2022 - Barcelona, Spain 26-29 August 2022}. 2022. Dostupné z: https://doi.org/10.1093/eurheartj/ehac544.1540.

Přehled o publikaci